echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > One billion retail oral hypoglycemic drugs fall into the "sacred altar" Zhengda Tianqing, Beite... hit the first imitation

    One billion retail oral hypoglycemic drugs fall into the "sacred altar" Zhengda Tianqing, Beite... hit the first imitation

    • Last Update: 2021-08-02
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Text | Bai Yu

    According to data from Mi Nei, in 2020, the sales scale of the terminal oral diabetic chemical drugs in Chinese urban physical pharmacies exceeds 6 billion yuan, and 12 of the TOP20 products have sales of more than 100 million yuan.


    The 6 billion market is making waves again, and 11 oral hypoglycemic drugs approved this year

    The 6 billion market is making waves again, and 11 oral hypoglycemic drugs approved this year

    Sales of oral diabetic drugs in physical pharmacies in cities in China in recent years (unit: 100 million yuan)

    Source: Mi Nei.


    In May of this year, the seventh national census showed that the population of 60 years and over was 264.


    Oral diabetes chemicals approved for marketing since 2021

    Source: Meinenet MED2.


    Since the beginning of this year, a total of 11 oral hypoglycemic drugs have been approved for marketing.


    One billion retail oral hypoglycemic drugs fall into the altar! Product TOP20 ranking changes

    One billion retail oral hypoglycemic drugs fall into the altar! Product TOP20 ranking changes

    2020 China's urban physical pharmacies TOP20 oral diabetic chemical products (unit: 100 million yuan)

    Source: Mi Nei.


    Note: Sales of less than 100 million yuan will be displayed as "*"

    The total market share of TOP20 products accounts for more than 80%, and the market concentration is relatively high


    Top 20 brand names of metformin hydrochloride tablets in Chinese urban physical pharmacies in 2020

    Source: Mi Nei.


    At present, there are more than 100 manufacturers of metformin hydrochloride tablets, and competition is fierce


    From the perspective of sales growth, sitagliptin-metformin tablets (II) and pioglitazone-metformin tablets (15mg/500mg) have the fastest growth rates, with strong growth rates of 54.


    27 oral hypoglycemic drugs swarmed! Zhengda Tianqing, Kelun, Better.


    Oral diabetes chemicals under review from 2018 to now

    Source: Meinenet MED2.


    Since 2018, a total of 27 oral hypoglycemic agents have submitted marketing applications for review and approval


    Dapagliflozin tablets, sitagliptin and metformin sustained-release tablets, titagliptin hydrobromide tablets, miglitol orally disintegrating tablets, troxagliptin succinate tablets, metformin hydrochloride oral solution, lubiprostone capsules No generic drugs have been approved for 8 products of metformin and vildagliptin tablets (Ⅲ)


    In addition, there are three new class 1 drugs, namely Jiangsu Hengrui Medicine's proline Henggligliflozin tablets, Repagliptin phosphate tablets, Chengdu Chipset Pharmaceuticals|Shenzhen Chiplets Biosciences Siglita sodium tablets


    Data source: Mi Neiwang database

    If there are any errors or omissions, please correct me!

    Note: China's urban entity pharmacy terminal competition pattern database is an enlarged version of the urban entity pharmacy database that covers 293 prefectures and cities across the country (excluding county and rural entity pharmacies), and continuously monitors all categories


    Original title: One billion retail oral hypoglycemic drugs fall into the "Altar"! TOP20 ranking changes, Chia Tai Tianqing, Beite.
    .
    .
    the first imitation of the impact

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.